Entrada Therapeutics Stock Price on November 4, 2024
| TRDA Stock | USD 19.83 0.46 2.37% |
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 19.83, as last reported on the 29th of November, with the highest price reaching 19.93 and the lowest price hitting 19.30 during the day. Entrada Therapeutics appears to be not too volatile, given 3 months investment horizon. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Entrada Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Entrada Therapeutics' Coefficient Of Variation of 1049.26, mean deviation of 2.37, and Downside Deviation of 3.16 to check if our risk estimates are consistent with your expectations.
At present, Entrada Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 13.8 M, whereas Total Stockholder Equity is forecasted to decline to about 153.3 M. . At present, Entrada Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.84, whereas Price To Sales Ratio is forecasted to decline to 3.10. Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Entrada |
Sharpe Ratio = 0.1452
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TRDA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.87 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Entrada Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.7565 | Enterprise Value Ebitda 5.775 | Price Sales 3.4476 | Shares Float 18.4 M | Wall Street Target Price 25.57 |
Entrada Therapeutics Main Headline on 4th of November 2024
Disposition of 749 shares by Natarajan Sethuraman of Entrada... by MacroaxisInsider
Filed transaction by Entrada Therapeutics Officer: President, Research & Develop.. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Entrada Therapeutics Valuation on November 4, 2024
It is possible to determine the worth of Entrada Therapeutics on a given historical date. On November 4, 2024 Entrada was worth 17.62 at the beginning of the trading date compared to the closed value of 17.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entrada Therapeutics stock. Still, in general, we apply an absolute valuation method to find Entrada Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entrada Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entrada Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 17.16 | 17.86 | 17.16 | 17.60 | 83,564 | |
11/04/2024 | 17.62 | 18.10 | 17.44 | 17.77 | 133,817 |
| 18.05 | 18.62 | 17.25 | 18.62 | 153,694 |
| Backtest Entrada Therapeutics | | | Entrada Therapeutics History | | | Entrada Therapeutics Valuation | Previous | Next |
Entrada Therapeutics Trading Date Momentum on November 4, 2024
| On November 05 2024 Entrada Therapeutics was traded for 18.62 at the closing time. The top price for the day was 18.62 and the lowest listed price was 17.25 . The trading volume for the day was 153.7 K. The trading history from November 5, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 4.78% . The overall trading delta against the current closing price is 11.87% . |
Entrada Therapeutics Fundamentals Correlations and Trends
By evaluating Entrada Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entrada Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entrada financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Entrada Therapeutics Stock history
Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 33.1 M | 34.8 M | |
| Net Loss | -85.2 M | -80.9 M |
Entrada Therapeutics Quarterly Net Working Capital |
|
Entrada Therapeutics Stock Technical Analysis
Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Entrada Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Entrada Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Entrada Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Entrada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entrada Therapeutics shares will generate the highest return on investment. By undertsting and applying Entrada Therapeutics stock market strength indicators, traders can identify Entrada Therapeutics entry and exit signals to maximize returns
Entrada Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0807 | |||
| Jensen Alpha | 0.0433 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0598 | |||
| Treynor Ratio | 0.1345 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Entrada Stock analysis
When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world |